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Liver endothelial cell (LEC) damage is essential in the pathogenesis of ischemia-reperfusion injury (IRI) in transplant recipients. We analyzed the mechanism of LEC resistance against IRI by using a novel recombinant soluble form of P selectin glycoprotein ligand 1, tandem P selectin glycoprotein ligand immunoglobulin (TSGL-Ig), in a mouse model of hepatic cold preservation (4°C in University of Wisconsin solution for 20 h) and syngeneic orthotopic liver transplantation (OLT). Unlike controls, TSGL-Ig protected orthotopic liver transplants against ischemia-reperfusion (IR) stress, shown by depressed serum alanine aminotransferase levels, well-preserved hepatic architecture, and improved survival (42% vs. 92%). TSGL-Ig suppressed neutrophil/macrophage sequestration and proinflammatory cytokine/chemokine programs in OLT. Treatment with TSGL-Ig mitigated LEC activation (P and E selectin, VCAM-1 and intercellular adhesion molecule 1 expression). In parallel in vitro studies, TSGL-Ig diminished cellular damage in H 2 O 2 -stressed LEC cultures (lactic acid dehydrogenase and alanine aminotransferase levels). Increased thioredoxin, glutamate-cysteine ligase, NAD(P)H quinone dehydrogenase 1, and hypoxia-inducible factor 1a expression, along with transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2), implied that TSGL-Ig exerts antioxidant functions in IR-stressed OLT and H 2 O 2 -stressed LECs. Indeed, Nrf2-deficient livers suffered fulminant IRI compared with WT despite concomitant TSGL-Ig therapy. Thus, TSGL-Ig is not only acting as a competitive antagonist blocking leukocyte migration into IR-stressed liver, but it may also act directly as an agonist stimulating Nrf2-mediated cytoprotection in LECs. This study supports the role of P selectin signaling in hepatic homeostasis in OLT, with broad implications for tissue damage conditions.
Introduction
Local sterile inflammation represents an innate immune signature of hepatic ischemia-reperfusion injury (IRI), an inevitable event in organ procurement, transplantation, partial hepatectomy, trauma, or shock. The IRI often results in hepatic nonfunction or dysfunction at the early posttransplant phase and may lead to increased incidence of acute and chronic rejection (1, 2) . In addition, IRI contributes to donor organ shortage because marginal livers are particularly susceptible to the ischemic insult. Despite recent progress, more studies are needed to further elucidate mechanisms of innate immunity-driven liver inflammation and to develop much needed new therapeutic concepts against hepatocellular damage triggered by ischemia-reperfusion (IR).
Liver endothelial cells (LECs) form the vascular wall of the hepatic sinusoid. With no organized basal membrane, microvascular endothelium allows macrophage and neutrophil infiltration, causing inflammatory reactions (3) (4) (5) . LECs play protective roles controlling vascular homeostasis, inflammation, vascular tone, and toxicant clearance. Insult to hepatic endothelium during cold preservation contributes to liver IRI, causing low graft microcirculation, upregulation of adhesion molecule expression, oxidative stress, and further augmenting neutrophil infiltration and hepatocyte necrosis (4, 5) .
The selectins, a family of lectin-domain glycoproteins expressed on endothelial cells, platelets, and leukocytes, mediate the initial capture and support leukocyte rolling on sinusoidal endothelial cells in the initial phase of IRI (6) . The principal selectin ligand, P selectin glycoprotein ligand 1 (PSGL-1, CD162) is the only known high-affinity ligand for P selectin in the cell adhesion cascade (7). We reported previously that treatment with recombinant P selectin glycoprotein ligand immunoglobulin (rPSGL-Ig) ameliorated hepatic IRI in rat liver models of cold ischemia followed by ex vivo isolated perfusion or syngeneic orthotopic liver transplantation (OLT) (8, 9) . Moreover, in a recent clinical trial at the University of California Los Angeles (UCLA), a short-term rPSGL-Ig therapy proved effective in deceased donor liver transplant patients with 6-mo follow-up (10).
The oxidative stress caused by excessive production of reactive oxygen species (ROS) is vital for hepatocellular insult in the pathophysiology of liver IRI (1,2,11). The Kelch-like ECH-associated protein 1 (Keap1), nuclear factor erythroid 2-related factor 2 (Nrf2), and antioxidant response element (ARE) signaling axis represents an essential trigger for adaptive oxidative stress response, processing of excessive ROS production, and maintaining the cellular redox balance and metabolism (12, 13) . This pathway consists of three components: Keap1, Nrf2, and AREs. The transcription factor Nrf2 belongs to the cap "n" collar family, with a conserved basic leucine zipper structure. It may protect cells against oxidative stress (13) and maintain the cellular redox balance by regulating endogenous antioxidants, phase 2 detoxification enzymes, and defensive proteins via AREs (14) . In basal conditions, Nrf2 is associated in the cytoplasm by Keap1, ubiquitinated by the cullin 3-Keap1 E3 ligase complex, and degraded by the proteasome pathway (15) . Keap1-mediated ubiquitination of Nrf2 is disrupted in response to oxidative stress, leading to Nrf2 stabilization. The level of Nrf2 protein is elevated correspondingly, and the transcription factor translocates into the nucleus, where it binds ARE-containing promoters. This triggers AREcontrolled expression of cytoprotective oxidative stress response enzymes, such as thioredoxin (Trx), glutamatecysteine ligase (GCL), and NAD(P)H quinone dehydrogenase 1 (NQO1) (16) .
To gain further insight into the putative role of adhesion molecule antagonism in hepatic inflammation and the acquisition of intracellular redox homeostasis, we constructed a new soluble recombinant Ig fusion molecule designated tandem P selectin glycoprotein ligand immunoglobulin (TSGL-Ig). In the TSGL-Ig construct, two P selectin sulfated glycopeptide-binding domains from human PSGL-1 (17, 18) are combined in a tandem configuration on a single polypeptide chain and fused to an inactivated human IgG1 Fc domain ( Figure 1A ). The TSGL-Ig construct enhances the selectin-binding properties of the previously described rPSGL-Ig, which has been widely studied and shown to act as a competitive antagonist for leukocyte binding to selectins both in vitro and in vivo (8-10).
The present study examines therapeutic effects and mechanisms by which the TSGL-Ig molecule targets hepatic IRI in a clinically relevant mouse liver transplant model subjected to a prolonged period of cold storage. Anticipating that TSGL-Ig would bind to selectins on activated endothelial cells, which play a key role in IRI, we tested whether TSGL-Ig homeostatic function also involves Nrf2 translocation/activation in LECs. Our novel findings suggest that TSGL-Ig binding to selectins on endothelial cells may mitigate cellular damage in IRstressed mouse liver grafts by exerting direct cytoprotection on LECs in an Nrf2-dependent manner.
Materials and Methods

Animals
Male WT mice aged 8-12 weeks (Jackson Laboratory, Bar Harbor, ME) and Nrf2-deficient mice (breeding pairs provided by Dr. T. Kensler, Johns Hopkins University, Baltimore, MD) on a C57BL/6 background (backcrossed for at least 12 generations) were used. Mice were housed in the UCLA animal facility under specific pathogen-free conditions and received humane care, as per the criteria outlined in Guide for the Care and Use of Laboratory Animals (prepared by the National Academy of Sciences; NIH publication 86-23, revised 1985).
OLT model
Livers from WT or Nrf2 KO mice were stored for 20 h at 4°C in University of Wisconsin (UW) solution prior to transplantation into syngeneic hosts (19) . Three groups of WT recipients were treated with TSGL-Ig, Livers from B6 mice, stored for 20 h at 4°C, were transplanted to syngeneic recipients. TSGL-Ig or control Ig was infused at donor liver harvest and prior to OLT reperfusion (100 lg per mouse via portal vein). (B) OLT survival (n = 12 per group). (C) sALT levels at 6 and 24 h after OLT (n = 6 per group). Means plus or minus standard deviation are shown (*p < 0.001). (D) OLT histology at 6 h. Representative of n = 4-6 per group (hematoxylin and eosin staining; magnification 9100 and 9400). Ctr, control; OLT, orthotopic liver transplantation; PSGL, P selectin glycoprotein ligand; rPSGL-Ig, recombinant P selectin glycoprotein ligand immunoglobulin; sALT, serum alanine aminotransferase; TSGL-Ig, tandem P selectin glycoprotein ligand immunoglobulin. rPSGL-Ig, or control Ig (100 lg per mouse via portal vein) at the time of liver harvest and immediately prior to reperfusion. The OLT and serum samples were collected at 6 and 24 h after transplant. The severity of liver IRI was graded with modified Suzuki's histologic criteria in which sinusoidal congestion, hepatocyte necrosis, and ballooning degeneration are graded from 0 to 4 (20) (21) (22) .
Warm liver IRI model
In a mouse model of segmental (70%) hepatic warm IRI, the arterial/ portal venous blood supply to the cephalad lobes was interrupted by an atraumatic clip for 90 min (22) . WT and Nrf2 KO mice were infused 1 h prior to the onset of liver ischemia with TSGL-Ig (100 lg intravenously) or control Ig. Mice were sacrificed at 6 h of reperfusion; liver and serum samples were collected. Sham-operated mice underwent the same procedure but without vascular occlusion.
Hepatocellular function assay
Serum alanine aminotransferase (sALT) levels were measured in blood samples by IDEXX Laboratories (Sacramento, CA).
Histopathology
Liver specimens (4 lm) stained with hematoxylin and eosin (H&E) were analyzed blindly (21, 22) . Primary mAb against mouse neutrophils (Ly-6G; 1A8; BD Biosciences, San Jose, CA) and macrophages (CD68; FA-11; AbD Serotec, Raleigh, NC) were used. Labeled cells were counted in 10 high-power fields. Superoxide levels in hepatic tissue were detected with the ROS-sensing dye dihydroethidium (DHE; AnaSpec, Fremont, CA).
Myeloperoxidase activity assay
The presence of myeloperoxidase (MPO) was used as an index of neutrophil accumulation in the liver (23) . An absorbance unit of MPO activity was defined as the quantity of enzyme degrading 1 mol/min of peroxide at 25°C/g of tissue.
Quantitative reverse transcriptase-polymerase chain reaction assay
Quantitative polymerase chain reaction (PCR) was used with the platinum SYBR green quantitative PCR kit (Invitrogen, Carlsbad, CA) with the Chromo 4 detector (MJ Research, Waltham, MA). Primers to amplify specific gene fragments were published (24) and are shown in Table S1 . Target gene expressions were calculated by their ratios to the housekeeping gene hypoxanthine-guanine phosphoribosyl transferase.
Western blot analysis
Cytosolic and nuclear proteins were isolated from OLT samples by the NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Scientific, Waltham, MA). Equal amounts of cytosolic and nuclear extracts were electrophoresed, blotted, and incubated with primary Nrf2 mAb (CST, Beverly, MA), secondary horseradish peroxidase-conjugated antibody and developed. b-Actin was used as a protein marker.
Cell cultures
Mouse LECs were isolated by in situ two-stage collagenase perfusion and cultured with complete Dulbecco's modified Eagle medium (Life Technologies, Grand Island, NY) for 24 h (25). LEC viability was 95-99%, and the purity was 97-99% (minimal contamination with ICAM-1 negative hepatocytes), assessed by intercellular adhesion molecule 1 (ICAM-1) staining (HA58; eBioscience, San Diego, CA) ( Figure S1A ). Hydrogen peroxide (H 2 O 2 , 0.2 mM; Sigma-Aldrich, St. Louis, MO) was used to trigger LEC necrosis, as described by us in primary murine hepatocyte cultures (26) . TSGL-Ig or control Ig (10 or 20 lg/mL) was added 1 h prior to H 2 O 2 -induced stress. At the conclusion of 6 h culture, LECs were stained with anti-rabbit Nrf2 mAb (CST) and donkey anti-rabbit Alexa Fluor 594 (Jackson ImmunoResearch Laboratories, West Grove, PA) as a secondary antibody. Alexa Fluor 488 actin conjugate (Life Technologies, Waltham, MA) was used to stain the cellular skeleton.
Lactic acid dehydrogenase/alanine aminotransferase release assay
Lactic acid dehydrogenase (LDH) and alanine aminotransferase (ALT) release into culture medium was measured with an LDH/ALT kit (Stanbio Laboratory, Boerne, TX) (24) .
Statistical analysis
All values are expressed as mean plus or minus standard deviation (SD). Data were analyzed with an unpaired, two-tailed Student t-test, and p < 0.05 was considered statistically significant.
Results
TSGL-Ig improves OLT survival and ameliorates hepatic IRI
We determined whether treatment with TSGL-Ig (100 lg per mouse via portal vein at liver harvest and reperfusion) promotes survival in mouse recipients of syngeneic OLT subjected to prolonged ex vivo cold storage (20 h at 4°C). Compared with 40% survival in the control Igtreated group (five of 12), >90% of OLT recipients conditioned with TSGL-Ig (11 of 12) remained alive at day 14 after transplant (p < 0.001) ( Figure 1B ).
Then we analyzed the hepatocellular function in recipients of IR-stressed OLT by screening sera and liver graft samples (6 h and day 1; n = 6 per group). Unlike controls, mice given TSGL-Ig were IR-resistant, as shown by reduced sALT levels (6 h: 16 694 AE 3670 vs. 3300 AE 711 U/L, respectively; 24 h: 5081 AE 1291 vs. 1041 AE 328 U/L, respectively; p < 0.001) ( Figure 1C ). The H&E staining at 6 h after OLT revealed wellpreserved hepatic architecture (minimal sinusoidal congestion; no lobular edema, vacuolization, or necrosis) with TSGL-Ig compared with Ig-treated controls ( Figure 1D ). These data correlated with Suzuki's histologic grading of hepatocellular damage at 6 h (2.8 AE 0.4 vs. 0.7 AE 0.5, respectively; p < 0.001) (data not shown).
In parallel, we set up separate groups of IR-stressed OLT recipients that were conditioned with original rPSGL-Ig (100 lg per mouse via portal vein at liver harvest and reperfusion). By 6 h of reperfusion, sALT levels were decreased (p < 0.01) in the treatment group (7218 AE 2471 U/L; n = 5) compared with controls (14 493 AE 4675 U/L; n = 4), implying that the TSGL-Ig molecule was somewhat more effective than rPSGL-Ig in targeting IRI and protecting the hepatocellular function ( Figure S2A ).
TSGL-Ig depresses neutrophil and macrophage sequestration in IR-stressed OLT
We used immunohistology to analyze and quantitate cell trafficking patterns at 6 h after OLT. P selectin blockade with TSGL-Ig markedly decreased recruitment of neutrophils (6 h: 8.40 AE 1.14 vs. 32.60 AE 2.41; p < 0.001) (Figure 2A ) and macrophages (6 h: 9.80 AE 1.48 vs. 24.80 AE 1.92; p < 0.001) ( Figure 2B ) in ischemic OLT. Consistent with immunostaining data, MPO assay, reflecting hepatic neutrophil activity, was decreased in TSGL-Ig-treated OLT compared with controls (6 h: 0.34 AE 0.07 vs. 0.80 AE 0.10 U/g, Figure 4B ). In addition, TSGL-Ig therapy protected LECs (yellow arrow) against IR-triggered necrosis/ apoptosis (red arrow) ( Figure 4B ).
TSGL-Ig differentially regulates IR-induced LEC activation
To determine LEC activation in vivo, we assessed messenger RNA (mRNA) levels coding for selectin and cell-A B adhesion proteins in IR-stressed OLT ( Figure 5A ). The quantitative reverse transcriptase-PCR (qRT-PCR)-assisted analysis of control grafts by 6 h or reperfusion revealed strong gene induction of P and E selectin and VCAM-1/ICAM-1, which declined thereafter. TSGL-Ig abolished (p < 0.001) the expression of LEC-associated cell adhesion genes in IR-resistant OLT.
TSGL-Ig mediates LEC cytoprotection in an Nrf2-dependent manner
Western blots have revealed that treatment with TSGL-Ig elevated both cytosolic and nuclear Nrf2 in IR-stressed OLT ( Figure 5B ). Unlike control OLT, TSGL-Ig increased the expression of Nrf2 downstream target genes, including Trx, GCL, NQO1, and hypoxia-inducible factor 1a (HIF-1a; p < 0.001) ( Figure 5C ).
To test molecular mechanisms of TSGL-Ig direct P selectin binding, primary LECs separated from WT livers were cultured with H 2 O 2 , an in vitro setting that mimics ROSmediated ischemia insult in liver grafts (26) . H 2 O 2 -stressaugmented LEC damage, measured by ALT and LDH release into the culture medium, was consistently suppressed (p < 0.05) after TSGL-Ig was added to the culture ( Figure 6A ).
By using immunofluorescence, we detected TSGLIg-triggered translocation of Nrf2 transcriptional activator into the LEC nucleus, with or without concomitant H 2 O 2 ( Figure 6B , white arrows). Consistent with the ability of Nrf2 to regulate the induction of ARE target gene promoter regions, TSGL-Ig increased the expression of Trx, GCL, NQO1, and HIF-1a in H 2 O 2 -stressed LECs (p < 0.001) compared with controls ( Figure 6C ).
We then used primary LECs from Nrf2 KO mice to analyze the mechanism of TSGL-Ig-mediated cytoprotection. Figure 7A ). In addition, TSGL-Ig failed to mitigate IR-triggered hepatocellular damage after disruption of Nrf2 signaling, as documented by liver H&E staining ( Figure 7B ), LEC activation (P and E selectin), and macrophage cytokine programs (TNF-a, IL-1b) ( Figure 7C ).
We used a murine model of hepatic partial warm IRI to confirm that TSGL-Ig protection against IR stress is Nrf2 White arrows indicate translocation of Nrf2 from cytoplasm to nucleus (representative of n = 3; magnification 9200); (C) Quantitative reverse transcriptase-polymerase chain reaction-assisted detection of P and E selectin, Trx, GCL, NQO1, and HIF-1a. Data normalized to HPRT gene expression. Means plus or minus standard deviation are shown (*p < 0.001; **p < 0.05, n = 4-6 per group). ALT, alanine aminotransferase; Ctr, control; GCL, glutamate-cysteine ligase; HIF-1a, hypoxia-inducible factor 1a; HPRT, hypoxanthine-guanine phosphoribosyl transferase; LDH, lactic acid dehydrogenase; LEC, liver endothelial cell; NQO1, NAD(P)H quinone dehydrogenase 1; Nrf2, nuclear factor erythroid 2-related factor 2; N.S., not significant; Trx, thioredoxin; TSGL-Ig, tandem P selectin glycoprotein ligand immunoglobulin. dependent. WT and Nrf2 KO mice subjected to 90 min of hepatic warm ischemia were pretreated with TSGL-Ig or control Ig (at À1 h intravenously); sera and liver samples were collected at 6 h of reperfusion, the peak of hepatocellular damage (22) . WT mice given TSGL-Ig were IRI resistant compared with controls, as shown by decreased sALT levels (p < 0.05) (Figure S3A ), wellpreserved hepatic architecture ( Figure S3B ), depressed LEC (P and E selectin), and macrophage (TNF-a, IL-1b) activation (p < 0.05) ( Figure S3C ). Consistent with our findings in cold-stored OLT, TSGL-Ig failed to abolish IR-mediated hepatocellular damage in Nrf2-deficient warm IR-stressed livers, as documented by sALT levels ( Figure S3A ), liver H&E staining ( Figure S3B) , and hepatic IRI cytokine signature/selectin expression patterns ( Figure S3C ).
A B
Discussion
We and others previously found that rPSGL-Ig acts as a competitive inhibitor of the initial tethering of leukocytes to activated platelets and endothelium by binding to selectins (8, 9, 27, 28) . Blockade of leukocyte tethering via the P selectin-PSGL-1 axis prevented hepatocellular damage in normal (8) and steatotic (9) rat liver models of extended cold storage and reperfusion ex vivo on an isolated perfusion machine or syngeneic OLT. Furthermore, our recent clinical phase II study in deceased donor liver transplant recipients with 6-mo follow-up documented the safety and beneficial impact of rPSGL-Ig on liver transplantation IRI, supported by therapeutic modulation of hepatic IRI biomarkers (10) . These findings were confirmed when rPSGL-Ig was used in renal transplant patients; a robust increase in inflammatory gene transcript levels during kidney transplantation IRI was reduced by inhibition of leukocyte adhesion (29) . In agreement with our clinical findings (10), we have now confirmed that rPSGL-Ig protected mouse syngeneic OLT against IRI, as shown by decreased sALT levels ( Figure S2A) ; reduced ROS production ( Figure S2B) ; enhanced Nrf2 nuclear translocation ( Figure S2C) ; and increased expression of Trx, GCL, NQO1, and HIF-1a, namely, Nrf2 downstream activation genes ( Figure S2D ).
Our current study is the first to use a newly generated TSGL-Ig molecule in a clinically relevant murine model of syngeneic OLT with a prolonged period (20 h) of cold ischemia. Preliminary surface plasmon resonance binding analysis indicated that TSGL-Ig has improved P selectin binding properties compared with rPSGL-Ig (G. D. Shaw, CA, unpublished data, 2016). While this improved binding would be expected to translate in vivo, the protective activity of TSGL-Ig in an experimental organ IRI model required confirmation. We showed that TSGL-Ig (i) improved OLT survival and ameliorated hepatic IRI, (ii) depressed neutrophil and macrophage sequestration along with proinflammatory cytokine and chemokine programs in IR-stressed OLT, (iii) diminished some aspects of LEC activation, and (iv) conferred cytoprotection against IR stress by acting directly as an agonist to stimulate Nrf2-mediated cytoprotection in liver endothelial cells. The new TSGL-Ig was somewhat more effective than the original rPSGL-Ig drug molecule in its ability to blunt IRI in OLT and to improve hepatocellular function.
In the pathogenesis of liver IRI, the endothelium damage determines poor graft microcirculation, platelet activation, persistent vasoconstriction, upregulation of adhesion molecules, oxidative stress, Kupffer cell activation, neutrophil infiltration, and eventually hepatocyte death (1,2,5) . The principal selectin ligand, PSGL-1, mediates the capturing and rolling of leukocytes on LECs in the initial phase of IRI (7, 30, 31) . The newly constructed TSGL-Ig has enhanced selectin binding activity compared with the corresponding soluble form of native human rPSGL-Ig. We asked whether TSGL-Ig would attenuate liver IRI and, if so, how it may preserve LEC integrity, as direct binding is essential to promote OLT survival. In a mouse model of liver extended cold storage (4°C UW solution for 20 h) and syngeneic OLT, the TSGL-Ig treatment group showed improved survival rates, preservation of hepatic architecture, and minimal overall liver damage. Consequently, TSGL-Ig is effective for combating hepatic IRI and maintaining homeostasis in IR-stressed mouse OLT.
In the initial IR-mediated inflammation phase, we found increased activation and recruitment of CD68-positive macrophages, consistent with preferential proinflammatory chemotactic gene expression pattern in IR-stressed livers (8, 9, 19, 21, 22) . Because rPSGL-Ig therapy suppressed macrophage function in rats (8, 9) , we expected that TSGL-Ig may work in a similar fashion in IR-stressed mouse livers. Indeed, TSGL-Ig treatment decreased CD68-positive macrophage infiltration and diminished their activation/function, as shown by immunohistology and expression of IRI signature markers, including TNF-a, IL1b, IFN-b, and CXCL-10.
Activated neutrophils generate ROS to promote IRstressed hepatocellular damage (11, 12) . Indeed, unlike sham controls, Ly-6G-positive neutrophil infiltration and MPO activity increased in control Ig-treated IRI. In contrast, livers in TSGL-Ig-conditioned mice were characterized by decreased neutrophil infiltration/MPO activity and depressed CXCL-1 levels, the key neutrophil chemoattractant. Because neutrophil activation and target tissue sequestration can be enhanced by macrophage-derived inflammatory cytokines, TSGL-Ig can exert its regulatory influence during liver IRI through cytokine and chemokine networks.
Both necrosis and apoptosis are responsible for IR hepatocyte damage (22) . ROS promotes mitochondrial permeability transition, leading to hepatocellular swelling, rupture of the plasma membrane, and release of cytochrome C, ultimately resulting in adenosine triphosphate depletion-dependent oncotic necrosis and caspasedependent apoptosis. Our present data show that TSGLIg suppressed ROS production (DHE staining) and inhibited oncotic necrosis/apoptosis in hepatocytes and endothelial cells in IR-stressed OLT.
We previously showed that rPSGL-Ig competitively bound P selectin to block leukocytic PSGL-1-P selectin . Ctr, control; HPRT, hypoxanthine-guanine phosphoribosyl transferase; Nrf2, nuclear factor erythroid 2-related factor 2; N.S., not significant; OLT, orthotopic liver transplantation; sALT, serum alanine aminotransferase; TNF-a, tumor necrosis factor a; TSGL-Ig, tandem P selectin glycoprotein ligand immunoglobulin.
interactions and to prevent hepatocellular injury (8) (9) (10) (32) . However, confirmation that TSGL-Ig agonistic activity is mediated solely via selectin binding will require further investigation.
By regulating cellular resistance against oxidative stress, the transcription factor Nrf2 has emerged as a "master switch" of intracellular redox homeostasis (12, 13) . We showed that mouse liver grafts with hepatocyte-specific Keap1 deficiency were IRI resistant (33) . The deficiency of Keap1-mediated ubiquitination of Nrf2 resulted in elevated hepatocyte Nrf2 activation. Because Nrf2 deficiency accelerated hepatocellular damage in IR-stressed livers, we postulated that Nrf2 should be considered as a denominator of donor liver quality. Western blot analysis of IRI-OLT and immunostaining in primary LEC cultures showed TSGL-Ig triggered translocation of Nrf2 transcriptional activator into the nucleus. After its binding to the ARE promoter, the gene inductions of Trx, GCL, NQO1, and HIF-1ɑ were all enhanced to exert cytoprotective and antioxidant functions. Furthermore, we determined whether TSGLIg may function through the ROS-Nrf2-ARE pathway using Nrf2 KO mice. Consistent with increased ALT/ LDH release levels, TSGL-Ig failed to protect Nrf2-deficient LECs from H 2 O 2 -inflicted stress in vitro. The failure of TSGL-Ig to ameliorate liver IRI in Nrf2 KO mice highlights a previously unrecognized role of selectins in antioxidant function by directly regulating LEC viability and promoting Nrf2-dependent cytoprotection.
The observed TSGL-Ig protection mediated via antioxidant Nrf2 in IRI cascade in the present study, along with recent identification of PSGL-1 as a key immune checkpoint regulator of T cell exhaustion (34) , highlight multifaceted functions of P selectin signaling beyond cell trafficking that have direct relevance to organ transplantation.
Supporting Information
Additional Supporting Information may be found in the online version of this article. The cytoprotective effects of tandem P selectin glycoprotein ligand immunoglobulin (TSGLIg) in livers subjected to warm ischemia were nuclear factor erythroid 2-related factor 2 dependent. Groups of WT and Nrf2 KO mice preconditioned with TSGL-Ig of control Ig (À1 h) were analyzed at 6 h of reperfusion after 90 min of warm hepatic ischemia-reperfusion insult. (A) Serum alanine aminotransferase levels. (B) Liver histology (representative of n = 3; hematoxylin and eosin staining; magnification 9100 and 9400). (C) Quantitative reverse transcriptase-polymerase chain reaction-assisted detection of tumor necrosis factor a, IL-1b, and P and E selectin.
Data normalized to hypoxanthine-guanine phosphoribosyl transferase gene expression. Means plus or minus standard deviation are shown (**p < 0.05, n = 3 per group). Table S1 : Primers used for quantitative reverse transcriptase-polymerase chain reaction analyses.
